Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Christina Santella"'
Autor:
Christina Santella, Elyse Tratt, Joy Nyamiaka, Louisa Whiteley Tukkiapik, Claire Styffe, Rachel Gamelin, Mary Ellen Macdonald, Paul Brassard
Publikováno v:
Qualitative Health Research. 32:1259-1272
Human papillomavirus (HPV) self-sampling offers a cervical cancer (CC) screening alternative that can address certain barriers to the Papanicolaou test. As part of a larger community-based participatory project in Nunavik, Northern Québec, we travel
Autor:
Richeek, Pradhan, Elisabetta, Patorno, Helen, Tesfaye, Sebastian, Schneeweiss, Hui, Yin, Jessica, Franklin, Ajinkya, Pawar, Christina, Santella, Oriana H Y, Yu, Christel, Renoux, Laurent, Azoulay
Publikováno v:
Am J Epidemiol
Case reports and a pharmacovigilance analysis have linked glucagon-like peptide 1 receptor agonists (GLP-1 RAs) with anaphylactic reactions, but real-world evidence for this possible association is lacking. Using databases from the United Kingdom (Cl
Autor:
Laurent Azoulay, Sophie Dell'Aniello, Antonios Douros, Samy Suissa, Paul Brassard, Christina Santella, Christel Renoux
Publikováno v:
Journal of Alzheimer's Disease. 81:329-338
Background: Previous studies suggested a link between various infectious pathogens and the development of Alzheimer’s disease (AD), posing the question whether infectious disease could present a novel modifiable risk factor. Objective: To assess wh
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 38:816-825
Background Recent interest has been geared towards the potential therapeutic and chemopreventive benefit of androgen deprivation therapy (ADT) for bladder cancer. As a result, several observational studies have investigated this potential association
Autor:
Armen Aprikian, Koray Tascilar, Christina Santella, Laurent Azoulay, Hui Yin, Adi J. Klil-Drori
Publikováno v:
Drug Safety. 42:1005-1011
Two recent observational studies have investigated the association between androgen deprivation therapy (ADT) and rheumatoid arthritis (RA), but generated discrepant findings and had important methodological limitations. Thus, the objective of this s
Autor:
Paul Brassard, Peter L. Lakatos, Christopher Filliter, Talat Bessissow, Alain Bitton, Christina Santella, Maria Vutcovici
Publikováno v:
Inflammatory bowel diseases. 28(2)
Background The specific contribution of anti-TNF therapy to the onset of herpes zoster (HZ) in patients with inflammatory bowel disease (IBD) remains uncertain. Thus, the purpose of this nested case-control study was to explore whether the use of ant
Autor:
Oriana Hoi Yun Yu, Laurent Azoulay, Hui Yin, Christina Santella, Blánaid Hicks, Nathaniel Bouganim
Publikováno v:
Santella, C, Yin, H, Hicks, B, Yu, O, Bouganim, N & Azoulay, L 2020, ' Weight-lowering effects of glucagon-like peptide-1 receptor agonists and detection of breast cancer among obese women with diabetes ', Epidemiology . https://doi.org/10.1097/EDE.0000000000001196
Background: It has been proposed that the weight loss associated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may improve the detection of breast cancer in patients undergoing this treatment. Thus, this study aimed to determine whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffee9aad8174269067a1da9cdba77e51
https://pure.qub.ac.uk/en/publications/weightlowering-effects-of-glucagonlike-peptide1-receptor-agonists-and-detection-of-breast-cancer-among-obese-women-with-diabetes(25324894-8741-4475-b372-0ceaed89d766).html
https://pure.qub.ac.uk/en/publications/weightlowering-effects-of-glucagonlike-peptide1-receptor-agonists-and-detection-of-breast-cancer-among-obese-women-with-diabetes(25324894-8741-4475-b372-0ceaed89d766).html
Testosterone Replacement Therapy and the Risk of Prostate Cancer in Men With Late-Onset Hypogonadism
Publikováno v:
American journal of epidemiology. 188(9)
The association between the use of testosterone replacement therapy (TRT) and prostate cancer remains uncertain. Thus, we investigated whether TRT is associated with an increased risk of prostate cancer in men with late-onset hypogonadism. We used th